serplulimab
fosun pharmaceuticals
['serplulimab', 'sclc']
the pd-1 antibody serplulimab in combination with carboplatin etoposide chemotherapy for extended newly diagnosed sclc vs. chemo. interim os 15.4 vs 10.9 (hr 0.63). longer folllow-up is needed #asco22 
MD, PhD - Asst Prof, Thoracic Oncology & Precision Medicine Unit Coordinator (CEMIC). Co-Founder PxMedica: https://t.co/6HpAi0RR9P